IL100811A - Synthetic peptides for poisoning bacteria of facial toxins and for the prevention and treatment of "shock" - Google Patents

Synthetic peptides for poisoning bacteria of facial toxins and for the prevention and treatment of "shock"

Info

Publication number
IL100811A
IL100811A IL10081192A IL10081192A IL100811A IL 100811 A IL100811 A IL 100811A IL 10081192 A IL10081192 A IL 10081192A IL 10081192 A IL10081192 A IL 10081192A IL 100811 A IL100811 A IL 100811A
Authority
IL
Israel
Prior art keywords
lys
peptide
phe
leu
cys
Prior art date
Application number
IL10081192A
Other languages
English (en)
Hebrew (he)
Other versions
IL100811A0 (en
Original Assignee
Porro Massimo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Porro Massimo filed Critical Porro Massimo
Publication of IL100811A0 publication Critical patent/IL100811A0/xx
Publication of IL100811A publication Critical patent/IL100811A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL10081192A 1991-02-11 1992-01-30 Synthetic peptides for poisoning bacteria of facial toxins and for the prevention and treatment of "shock" IL100811A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65874491A 1991-02-11 1991-02-11
US07/819,893 US5371186A (en) 1991-02-11 1992-01-16 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock

Publications (2)

Publication Number Publication Date
IL100811A0 IL100811A0 (en) 1992-09-06
IL100811A true IL100811A (en) 1999-07-14

Family

ID=25229363

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10081192A IL100811A (en) 1991-02-11 1992-01-30 Synthetic peptides for poisoning bacteria of facial toxins and for the prevention and treatment of "shock"

Country Status (16)

Country Link
US (2) US5371186A (sv)
EP (1) EP0623144B1 (sv)
JP (1) JPH07505606A (sv)
AT (1) ATE212355T1 (sv)
AU (1) AU665945B2 (sv)
CA (1) CA2123576A1 (sv)
DE (1) DE69232378T2 (sv)
DK (1) DK0623144T3 (sv)
ES (1) ES2172506T3 (sv)
FI (1) FI943396A (sv)
HU (1) HUT69707A (sv)
IE (1) IE920437A1 (sv)
IL (1) IL100811A (sv)
NZ (1) NZ241446A (sv)
TW (1) TW215441B (sv)
WO (1) WO1993014115A1 (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652211A (en) * 1991-02-11 1997-07-29 Biosynth S.R.L. Peptides for neutralizing the toxicity of Lipid A
US5371186A (en) * 1991-02-11 1994-12-06 Biosynth S.R.L. Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
US5733872A (en) * 1993-03-12 1998-03-31 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5610075A (en) * 1995-01-17 1997-03-11 Stahl-Rees; Marianne Competitive electrochemiluminescence assays for endotoxins using a ruthenium label
US5834430A (en) * 1995-05-31 1998-11-10 Biosynth S.R.L. Potentiation of antibiotics
WO1998035665A1 (fr) * 1997-02-14 1998-08-20 Ajinomoto Co., Inc. Antagonistes des endotoxines
AU759636B2 (en) 1997-07-31 2003-04-17 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
US6583110B1 (en) 1997-09-05 2003-06-24 Robert W. Finberg Use of agents which bind G proteins for treating septic shock
US6194562B1 (en) 1998-04-22 2001-02-27 Promega Corporation Endotoxin reduction in nucleic acid purification
US7078224B1 (en) * 1999-05-14 2006-07-18 Promega Corporation Cell concentration and lysate clearance using paramagnetic particles
US6951652B2 (en) * 1998-07-29 2005-10-04 Biosynth S.R.L. Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases
US6116663A (en) * 1998-10-19 2000-09-12 Cercueils Vic Royal, Inc. Casket Lock
DE10117043A1 (de) * 2001-04-05 2002-11-07 Gerhard Puetz Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen
WO2003094961A1 (en) * 2002-05-09 2003-11-20 Massimo Porro Improved polysaccharide and glycoconjugate vaccines_____________
PT2255826E (pt) 2002-08-02 2016-06-08 Glaxosmithkline Biologicals Sa Composições de vacina de neisseria compreendendo uma combinação de antigénios
AU2002368447A1 (en) * 2002-12-06 2004-06-30 Biosynth S.R.L. Broad-spectrum lps based vaccines of unencapsulated strains ofhaemophilus influenzae and other pathogenic species of gram-negative bacteria
GB2408263A (en) * 2003-11-14 2005-05-25 Pacgen Biopharmaceuticals Inc Antimicrobial peptides with reduced hemolysis and methods of their use.
CA2550927A1 (en) 2003-12-23 2005-07-14 Glaxosmithkline Biologicals S.A. A gram negative bacterium with reduced lps level in the outer membrane and use thereof for treating gram negative bacterial infection
EP1712559A1 (en) * 2005-04-11 2006-10-18 Sanofi Pasteur Polymyxin B analogs for LPS detoxification
US7507718B2 (en) 2005-04-11 2009-03-24 Sanofi Pasteur Polymyxin B analogs for LPS detoxification
CA2603850A1 (en) * 2005-04-11 2006-10-19 Sanofi Pasteur Polymyxin b analogs for lps detoxification
US8030034B2 (en) 2005-12-09 2011-10-04 Promega Corporation Nucleic acid purification with a binding matrix
US20090123499A1 (en) 2006-06-12 2009-05-14 Nathalie Devos Vaccine
ES2350430B1 (es) * 2009-05-28 2011-11-18 Fundacion De La Comunidad Valenciana Centro De Investigacion Principe Felipe,95%. Conjugado polimerico para el tratamiento de infecciones bacterianas
TWI548746B (zh) * 2009-08-06 2016-09-11 英特威特國際股份有限公司 防備豬胸膜肺炎之疫苗及製備該疫苗之方法
US8039613B2 (en) 2009-08-28 2011-10-18 Promega Corporation Methods of purifying a nucleic acid and formulation and kit for use in performing such methods
US8222397B2 (en) 2009-08-28 2012-07-17 Promega Corporation Methods of optimal purification of nucleic acids and kit for use in performing such methods
JP2013521327A (ja) 2010-03-10 2013-06-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
KR101858840B1 (ko) * 2016-01-15 2018-05-16 단국대학교 천안캠퍼스 산학협력단 집먼지진드기 유래 알레르겐에 의한 과민반응 면역조절제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340012C (en) * 1987-08-17 1998-08-25 Trustees Of Leland Stanford Jr. University Peptide determinant associated with immunity
US5593966A (en) * 1989-03-31 1997-01-14 The United States Of America As Represented By The Department Of Health And Human Services Peptide derivatives of cytochrome b558 and their use as medicaments
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
US5371186A (en) * 1991-02-11 1994-12-06 Biosynth S.R.L. Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
ZA92943B (en) * 1991-02-11 1992-11-25 Porro Massimo Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock

Also Published As

Publication number Publication date
FI943396A0 (sv) 1994-07-15
AU1691492A (en) 1993-08-03
AU665945B2 (en) 1996-01-25
CA2123576A1 (en) 1993-07-22
HU9401970D0 (en) 1994-09-28
JPH07505606A (ja) 1995-06-22
HUT69707A (en) 1995-09-28
EP0623144A1 (en) 1994-11-09
US5371186A (en) 1994-12-06
WO1993014115A1 (en) 1993-07-22
ES2172506T3 (es) 2002-10-01
NZ241446A (en) 1995-03-28
IE920437A1 (en) 1992-08-12
FI943396A (sv) 1994-07-15
TW215441B (sv) 1993-11-01
DE69232378D1 (de) 2002-03-14
DK0623144T3 (da) 2002-05-13
IL100811A0 (en) 1992-09-06
US5589459A (en) 1996-12-31
DE69232378T2 (de) 2002-10-31
EP0623144B1 (en) 2002-01-23
ATE212355T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
AU665945B2 (en) Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock
IE83655B1 (en) Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock
EP0093652B1 (fr) Toxine synthétique ST, son procédé de préparation et son application comme agent vaccinant
Siemion et al. Tuftsin: on the 30-year anniversary of Victor Najjar’s discovery
JPH06501938A (ja) ペプチドよりなるｈｉｖ複製阻害剤
JPH11508275A (ja) 代謝に対する安定性および細胞膜透過性が改善されたペプチドおよびペプチド核酸の環状プロドラッグ
AU683920B2 (en) Peptides for neutralizing the toxicity of lipid A
US5583198A (en) Amino acids, peptides or derivatives thereof coupled to fats
Luker et al. Tracheal cytotoxin structural requirements for respiratory epithelial damage in pertussis
US5358933A (en) Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
US6455244B1 (en) Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agents
RU2439077C2 (ru) Белоксвязывающие производные метотрексата и содержащие их лекарства
KR100360975B1 (ko) 위장운동자극활성을가지는폴리펩티드
JPH08504210A (ja) 結合生物活性ペプチドを使用した敗血症性ショックの治療
EP0149581B1 (fr) Nouvelles compositions contenant des oligo-muramylpeptides et leur application, notamment pour l'activation des macrophages
Bahr et al. Analysis of the antigenic relationship of various derivatives of N-acetyl-muramyl-L-ala-D-isoglutamine (MDP), using anti-MDP antibodies
JPH06505001A (ja) ２ａ因子阻害剤
CA2173856A1 (en) Compounds useful in anti-allergy treatment
JPH04221397A (ja) 水溶性ポリペプチド誘導体とその用途
RU2146681C1 (ru) Опиоидные пептиды и фармацевтическая композиция
Luker Structure-activity correlation for tracheal cytotoxin: defining a novel muramyl peptide interaction site
AU649242B2 (en) Amino acids, peptides or derivatives thereof coupled to fats
Birr Synthetic small thymic peptides: an immunoregulatory concept
JPS60155195A (ja) 新規合成ペプチド、その製法及びそれを含む医薬
JPH07503013A (ja) メチレンホスフィン酸を含むペプチド連結単位

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees